COVID-19 vaccine effectiveness in patients with hematologic malignancy.

Shah, Dimpy P; Shah, Pankil K; Thompson, Michael A

Shah, Dimpy P; Shah, Pankil K; Thompson, Michael A.

Affiliation

Shah DP; Mays Cancer Center at UTHealth San Antonio MD Anderson, San Antonio, Texas, USA.
Shah PK; Mays Cancer Center at UTHealth San Antonio MD Anderson, San Antonio, Texas, USA.
Thompson MA; Tempus Labs, Chicago, Illinois, USA.

Transpl Infect Dis ; 24(6): e13850, 2022 12.

Article in En | MEDLINE | ID: mdl-35584967

Subject(s)

COVID-19; Hematologic Neoplasms; Humans; COVID-19 Vaccines; Vaccine Efficacy; COVID-19/prevention & control; Hematologic Neoplasms/complications

Key words

SARS-CoV-2; blood cancer; breakthrough infections; leukemia; lymphoma; vaccine effectiveness

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Limits: Humans Language: En Journal: Transpl Infect Dis Journal subject: TRANSPLANTE Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google